Parental preferences toward genomic sequencing for non-medically actionable conditions in children: a discrete-choice experiment
- PMID: 28771249
- PMCID: PMC5868968
- DOI: 10.1038/gim.2017.93
Parental preferences toward genomic sequencing for non-medically actionable conditions in children: a discrete-choice experiment
Abstract
PurposeApplication of whole-exome and whole-genome sequencing is likely to increase in clinical practice, public health contexts, and research. We investigated how parental preference for acquiring information from genome-scale testing is influenced by the characteristics of non-medically actionable genetic disorders in children, as well as whether the preferences differed by gender and between African-American and white respondents.MethodsWe conducted a Web-based discrete-choice experiment with 1,289 parents of young children. Participants completed "choice tasks" based on pairs of profiles describing sequencing results for hypothetical genetic disorders, selected the profile in each pair that they believed represented the information that would be more important to know, and answered questions that measured their level of distress.ResultsKnowing the likelihood that the disorder would develop given a true-positive test result was most important to parents. Parents showed greater interest in learning sequencing results for disease profiles with more severe manifestations. This was associated with greater distress. Differences by gender and race reflected small differences in magnitude, but not direction.ConclusionParents preferred to learn results about genetic disorders with more severe manifestations, even when this knowledge was associated with increased distress. These results may help clinicians support parental decision making by revealing which types of sequencing results parents are interested in learning.
Conflict of interest statement
Megan Lewis – Declares no conflict of interest.
Alex Stine – Declares no conflict of interest.
Ryan Paquin – Declares no conflict of interest.
Carol Mansfield – Declares no conflict of interest
Dallas Wood – Declares no conflict of interest
Christine Rini – Declares no conflict of interest.
Myra Roche – Declares no conflict of interest.
Cynthia Powell – Declares no conflict of interest.
Jonathan Berg – Declares no conflict of interest.
Donald Bailey currently receives funding from The John Merck Fund and Ovid Therapeutics.
Figures


References
-
- Howard HC, Knoppers BM, Cornel MC, Wright Clayton E, Senecal K, Borry P. Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes. Eur J Hum Genet. 2015;23(12):1593–1600. doi: 10.1038/ejhg.2014.289. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical